Litcius/Paper detail

A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial

Ke Hu, Mengmei Wang, Yang Zhao, Yunting Zhang, Tao Wang, Zhishui Zheng, Xiaochen Li, Shaolin Zeng, Dong Zhao, Honglin Li, Ke Xu, Ke Lan

2020Virologica Sinica82 citationsDOIOpen Access PDF

Topics & Concepts

LeflunomideMedicineDihydroorotate dehydrogenaseAntiviral drugAdverse effectPlaceboInternal medicineDrugPharmacologyImmunologyRheumatoid arthritisPathologyEnzymeBiologyBiochemistryAlternative medicineBiochemical and Molecular ResearchNeonatal Health and BiochemistryDiabetes and associated disorders
A Small-Scale Medication of Leflunomide as a Treatment of COVID-19 in an Open-Label Blank-Controlled Clinical Trial | Litcius